Adjuvant treatment for colorectal cancer.
作者信息
Slevin M L
出版信息
BMJ. 1996 Feb 17;312(7028):392-3. doi: 10.1136/bmj.312.7028.392.
Abstract
摘要
相似文献
1
Adjuvant treatment for colorectal cancer.结直肠癌的辅助治疗。
BMJ. 1996 Feb 17;312(7028):392-3. doi: 10.1136/bmj.312.7028.392.
2
[Adjuvant chemotherapy in cancer of the colon].[结肠癌的辅助化疗]
Tumori. 2000 May-Jun;86(3 Suppl):S20-2. doi: 10.1177/03008916000863S106.
3
Adjuvant chemotherapy.辅助化疗
Lancet. 2000 Oct 7;356(9237):1276. doi: 10.1016/S0140-6736(05)73882-4.
4
The role of adjuvant chemotherapy in the treatment of colorectal cancer.辅助化疗在结直肠癌治疗中的作用。
Hematol Oncol Clin North Am. 1997 Aug;11(4):699-719. doi: 10.1016/s0889-8588(05)70457-3.
5
6
7
Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.结直肠癌缺失蛋白表达作为结直肠癌患者辅助化疗反应的一种可能预测指标。
Dis Colon Rectum. 2004 Jul;47(7):1216-24. doi: 10.1007/s10350-004-0552-9. Epub 2004 May 19.
8
[Combined therapy of rectal tumors: the chemotherapy].直肠肿瘤的联合治疗：化疗
Tumori. 2001 Jan-Feb;87(1 Suppl 1):S31-2.
9
10
[The adjuvant chemotherapy of obstructive colonic cancer].[梗阻性结肠癌的辅助化疗]
Lik Sprava. 1998 Oct-Nov(7):105-7.
引用本文的文献
1
Adequacy of Surgical Pathology Reports of Colorectal Carcinoma and Its Significance.结直肠癌手术病理报告的充分性及其意义
Cureus. 2021 Aug 6;13(8):e16965. doi: 10.7759/cureus.16965. eCollection 2021 Aug.
2
Colorectal cancer pathology reporting: a regional audit.结直肠癌病理报告：一项区域审计
J Clin Pathol. 1997 Feb;50(2):138-42. doi: 10.1136/jcp.50.2.138.
3
Adjuvant treatment for colorectal cancer. Concerns about chemotherapy are legitimate.结直肠癌的辅助治疗。对化疗的担忧是合理的。
BMJ. 1996 Jun 1;312(7043):1417-8. doi: 10.1136/bmj.312.7043.1417a.
4
Adjuvant treatment for colorectal cancer. Reducing avoidable delays in establishing the diagnosis is also important.结直肠癌的辅助治疗。减少确诊过程中可避免的延误也很重要。
BMJ. 1996 Jun 1;312(7043):1417. doi: 10.1136/bmj.312.7043.1417.
本文引用的文献
1
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.亚叶酸钙调节的氟尿嘧啶作为原发性结肠癌术后辅助治疗的益处：来自国家外科辅助乳腺和肠道项目C-03方案的结果。
J Clin Oncol. 1993 Oct;11(10):1879-87. doi: 10.1200/JCO.1993.11.10.1879.
2
The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.胸苷酸合成酶表达在直肠癌患者辅助化疗预后及结局中的作用
J Clin Oncol. 1994 Dec;12(12):2640-7. doi: 10.1200/JCO.1994.12.12.2640.
3
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.单克隆抗体用于 Dukes' C 期结肠癌切除术后辅助治疗的随机试验。德国癌症援助组织 17-1A 研究小组。
Lancet. 1994 May 14;343(8907):1177-83. doi: 10.1016/s0140-6736(94)92398-1.
4
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.氟尿嘧啶加左旋咪唑作为Ⅲ期结肠癌切除术后的有效辅助治疗：最终报告
Ann Intern Med. 1995 Mar 1;122(5):321-6. doi: 10.7326/0003-4819-122-5-199503010-00001.
5
Survival after postoperative combination treatment of rectal cancer.
N Engl J Med. 1986 Nov 13;315(20):1294-5. doi: 10.1056/NEJM198611133152014.
6
Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01.结肠癌术后辅助化疗或卡介苗治疗：NSABP C-01方案的结果
J Natl Cancer Inst. 1988 Mar 2;80(1):30-6. doi: 10.1093/jnci/80.1.30.
7
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.大肠癌的手术辅助治疗：左旋咪唑及左旋咪唑与氟尿嘧啶联合应用的评估。北中部癌症治疗组和梅奥诊所。
J Clin Oncol. 1989 Oct;7(10):1447-56. doi: 10.1200/JCO.1989.7.10.1447.
8
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.左旋咪唑与氟尿嘧啶用于切除术后结肠癌的辅助治疗。
N Engl J Med. 1990 Feb 8;322(6):352-8. doi: 10.1056/NEJM199002083220602.
9
Effective surgical adjuvant therapy for high-risk rectal carcinoma.高危直肠癌的有效手术辅助治疗
N Engl J Med. 1991 Mar 14;324(11):709-15. doi: 10.1056/NEJM199103143241101.
Zotero 插件